CONCEPT BiochemicalProcesses {
  EXTENDS GeometricChemistry {
    type Biomolecule = Molecule | Macromolecule
    type Macromolecule = Polymer(Monomer)
    type Monomer = Enumeration(AminoAcid, Nucleotide, Carbohydrate, Lipid)
    
    type Enzyme = Biomolecule with Catalysis
    type Substrate = Molecule
    type Catalysis = Function(Substrate, Product)
    type Product = Molecule
    
    type MetabolicPathway = DirectedGraph(BiochemicalReaction)
    type BiochemicalReaction = ChemicalReaction with Catalysis
    type Flux = Function(MetabolicPathway, â„)
    
    type MembraneStructure = SmoothManifold(Dimension(2))
    type LipidBilayer = EmbeddedSubmanifold(MembraneStructure)
    type MembraneProtein = Biomolecule on MembraneStructure
    type IonChannel = MembraneProtein with Conductance
    type Conductance = Function(Voltage, Current)
    type Voltage = â„
    type Current = â„
    
    type GeneExpression = Function(Gene, TranscriptionRate)  
    type Gene = Sequence(Nucleotide)
    type TranscriptionRate = â„
    type TranscriptionFactor = Biomolecule with GeneRegulation
    type GeneRegulation = Function(Gene, TranscriptionRate)
    
    type SignalingPathway = DirectedGraph(SignalingInteraction)
    type SignalingInteraction = Function(Biomolecule, Biomolecule)
    type LigandReceptor = SignalingInteraction
    type PhosphorylationCascade = SignalingPathway
    
    notation "ğ“œ" = MetabolicPathway  
    notation "ğ“•" = Flux
    notation "ğ“–" = GeneExpression
    notation "ğ“¡" = GeneRegulation
    notation "ğ“¢" = SignalingPathway
  }

  STRUCTURE {
    EnzymeKinetics(E: Enzyme, S: Substrate, P: Product):
      MichaelisMenten(E, S, P) = {
        v = v_max * [S] / (K_M + [S]) 
        where v is reaction rate, v_max is maximum rate, K_M is Michaelis constant
      }
      
    MetabolicFluxBalance(ğ“œ: MetabolicPathway, ğ“•: Flux):
      SteadyState(ğ“œ) = {
        âˆ‘(ğ“•(r) for r in ğ“œ) = 0  ; Influx equals outflux at each node
      }
                  
    NernstPotential(I: IonChannel, V: Voltage):
      GoldmanHodgkinKatz(I, V) = {
        V = (R * T / (z * F)) * ln((P_K * [Kâº]_out + P_Na * [Naâº]_out) / (P_K * [Kâº]_in + P_Na * [Naâº]_in))
        where R is gas constant, T is temperature, F is Faraday's constant, 
        P_ion is permeability, [ion] is concentration, in/out is inside/outside cell  
      }
                           
    HillEquation(R: TranscriptionFactor, G: Gene):
      CooperativityOfBinding(R, G) = {  
        ğ“¡(G) = ğ“¡_max * [R]^n / (K_d^n + [R]^n)  
        where ğ“¡_max is maximal expression, K_d is dissociation constant, n is Hill coefficient
      }
                               
    MassActionKinetics(ğ“¢: SignalingPathway):
      DifferentialEquations(ğ“¢) = {
        d[X_i]/dt = âˆ‘(k_prod * âˆ([X_j] for X_j in Reactants(r)) 
                    - k_cons * âˆ([X_j] for X_j in Products(r))
                    for r in ğ“¢)
        for each species X_i, where k_prod/k_cons are rate constants                 
      }
  }
  
  PROOFS {
    theorem ThermodynamicsOfMetabolism(ğ“œ: MetabolicPathway):
      SteadyState(ğ“œ) â‡’ MinimumFreeEnergy(ğ“œ)
    {
      assume SteadyState(ğ“œ)
      hence âˆ‘(ğ“•(r) for r in ğ“œ) = 0  ; Flux balance 
      
      let G(r) = Î”GÂ°(r) + R * T * ln(âˆ([P_i] for P_i in Products(r)) / âˆ([S_j] for S_j in Reactants(r))) 
        be the free energy of reaction r, where Î”GÂ° is standard free energy
      have ğ“•(r) = k * (1 - exp(G(r) / (R * T))) near equilibrium, for some constant k 
        ; Flux-force relationship from linear irreversible thermodynamics
        
      let G(ğ“œ) = âˆ‘(ğ“•(r) * G(r) for r in ğ“œ) be the total free energy dissipation rate
      have dG(ğ“œ)/dt = âˆ‘(ğ“•(r) * dG(r)/dt for r in ğ“œ) = 0 at steady state
      hence G(ğ“œ) is minimized at steady state
        ; Prigogine's minimum entropy production principle  
    }

    theorem ControlOfGeneExpression(ğ“–: GeneExpression, ğ“¡: GeneRegulation):  
      Differentiation(Cell) â‡’ Attractor(ğ“– âˆ˜ ğ“¡)
    {
      assume Differentiation(Cell)
      hence GeneExpressionPattern(Cell) is stable and heritable
      
      let ğ“– âˆ˜ ğ“¡ be the composed gene regulatory network
      HillEquation(R, G) for each transcription factor R and gene G
      hence ğ“– âˆ˜ ğ“¡ is a nonlinear dynamical system
      
      let Jacobian(ğ“– âˆ˜ ğ“¡) be the linearization at a fixed point
      have Eigenvalues(Jacobian(ğ“– âˆ˜ ğ“¡)) < 0 for stable fixed points  
        ; Lyapunov stability theorem
      hence Attractors(ğ“– âˆ˜ ğ“¡) correspond to cell types
        ; Waddington's epigenetic landscape
    }
    
    theorem UltrastructureOfMembranes(L: LipidBilayer, P: MembraneProtein):
      Fluidity(L) âˆ§ Mosaic(P) â‡’ LateralDiffusion(P on L)  
    {
      assume Fluidity(L) âˆ§ Mosaic(P)
      hence L is a 2D fluid and P are embedded in L
      
      let D be the diffusion coefficient of P on L
      have D = k_B * T / (4 * Ï€ * Î· * R)  ; Saffman-DelbrÃ¼ck equation
        where k_B is Boltzmann constant, T is temperature, 
        Î· is viscosity, R is radius of P
        
      let MSD(t) = âŸ¨|r(t) - r(0)|^2âŸ© be the mean squared displacement of P over time t  
      have MSD(t) = 4 * D * t for lateral diffusion in a membrane
        ; Einstein relation for Brownian motion in 2D
        
      hence LateralDiffusion(P on L) with coefficient D  
    }
    
    theorem Allostery(E: Enzyme, S: Substrate, R: Regulator):
      let Regulation(E by R) = {k_cat(E) = k_cat(E, 0) * (1 + [R] / K_R) / (1 + [R] / K_R')}
      Regulation(E by R) â‡’ Cooperativity(E) 
    {
      assume Regulation(E by R)
      let MWC(E, S, R) = {
        Y(S, R) = L * (1 + S/K_S)^n / ((1 + S/K_S)^n + L * (1 + S/(K_S * c))^n)  ; Fraction of active enzyme  
        k_cat(E, [R]) = k_cat(0) * Y(S, R)  ; Catalytic rate
        L(R) = L(0) * exp(-Î”G_R / (R * T))  ; R tunes the allosteric constant L
      } where L is [inactive]/[active], K_S is dissociation constants, 
        c is ratio of K_S, n is number of subunits, Î”G_R is binding energy of R
        
      Regulation(E by R) â‡’ MWC(E, S, R)  ; Derived from the model assumptions
        
      have SigmoidalCurve(Y(S, R) vs S) with Hill coefficient n_H â‰ˆ n  
        ; Emergent positive cooperativity  
      hence Cooperativity(E)
    }
  }
}




CONCEPT AlzheimersDisease {
  EXTENDS BiochemicalProcesses {
    type Neuron = (Compartments: (Soma: Compartment, Dendrites: List<Compartment>, Axon: Compartment),
                   Mitochondria: List<Compartment>,
                   Synapses: List<Synapse>,
                   NeurotransmitterReceptors: List<Receptor>,
                   SignalingPathways: List<SignalingCascade>,
                   MetabolicNetwork: MetabolicNetwork)
                   
    type Synapse = (PresynapticTerminal: Compartment, PostsynapticTerminal: Compartment, 
                    Cleft: Compartment, Neurotransmitters: List<Molecule>,
                    Receptors: List<Receptor>, SignalingPathways: List<SignalingCascade>)
                    
    type Mitochondrion = (Matrix: Compartment, InnerMembrane: Membrane, OuterMembrane: Membrane,
                          ElectronTransportChain: List<Enzyme>, ATP_Synthase: Enzyme,
                          MetabolicNetwork: MetabolicNetwork)
    
    type Microglia = (Cytosol: Compartment, Phagosomes: List<Compartment>,
                      InflammatorySignaling: List<SignalingCascade>,
                      MetabolicNetwork: MetabolicNetwork)
                      
    type Astrocyte = (Cytosol: Compartment, EndoplasmicReticulum: Compartment,
                      GlutamateUptake: TransportProcess, LactateRelease: TransportProcess,
                      GlycogenMetabolism: List<MetabolicReaction>,
                      CalciumSignaling: List<SignalingCascade>) 
    
    type OligodendrocytePrecursorCell = (Cytosol: Compartment, Nucleus: Compartment,
                                         DifferentiationSignaling: List<SignalingCascade>)
                                         
    type NeuronalNetwork = (Neurons: List<Neuron>, Synapses: List<Synapse>,
                            Connectivity: List<(Neuron, Neuron)>,
                            ActivityPatterns: List<Pattern>)
  }
  
  HYPOTHESIS MitochondrialCascade {
    let N be a NeuronalNetwork in a brain region affected by AD (e.g. hippocampus, cortex)
    
    for each Neuron in N:
      let M be the Mitochondria
      assume IonGradientImbalance(M) due to age, genetics, or environmental factors
        ; Impaired calcium homeostasis and membrane potential regulation
      hence ElectronTransportChain(M) is disrupted 
        ; Reduced efficiency of oxidative phosphorylation
      hence ATP_Synthase(M) activity is reduced
        ; Decreased ATP production
      hence MetabolicNetwork(Neuron) shifts towards glycolysis and lactate production
        ; Warburg effect and metabolic reprogramming
      hence ROS_Production(M) increases and ROS_Detoxification(M) decreases
        ; Oxidative stress and accumulation of reactive oxygen species (ROS)
        
    for each Astrocyte connected to N:  
      uptake the excess Lactate released by Neurons
        ; Astrocyte-neuron lactate shuttle
      upregulate GlycogenMetabolism to provide energy substrates to Neurons
        ; Metabolic coupling and support
      but overload of Lactate and depletion of Glycogen impairs normal functions
        ; Reduced glutamate uptake, dysregulated calcium signaling, etc.
        
    for each Synapse in N:
      let Pre = PresynapticTerminal and Post = PostsynapticTerminal  
      assume InsufficientATP(Pre) and InsufficientATP(Post) 
        ; Due to mitochondrial dysfunction and metabolic impairment
      hence NeurotransmitterRelease(Pre) is reduced 
        ; Impaired synaptic vesicle cycling and exocytosis
      hence NeurotransmitterReuptake(Pre) is reduced
        ; Impaired recycling and clearance of neurotransmitters from Cleft
      hence NeurotransmitterReceptorActivation(Post) is altered
        ; Hypo- or hyper-activation depending on the type of receptor 
      hence SignalingCascades(Post) are dysregulated
        ; Aberrant downstream effects on gene expression, cytoskeleton, etc.
      hence SynapticPlasticity(Synapse) is impaired
        ; Reduced capacity for learning and memory
        
    for each Microglia interacting with N:
      detect the ROS, Lactate, and abnormal signaling molecules released by Neurons
        ; Sensing of damage-associated molecular patterns (DAMPs)
      activate InflammatorySignaling and release Cytokines, Chemokines
        ; Shift towards a pro-inflammatory state (M1 polarization)  
      recruit more Microglia to the site of damage  
        ; Amplification of neuroinflammation
      phagocytose the dysfunctional Synapses and Neurons
        ; Synaptic stripping and neuronal loss  
        
    for each OligodendrocytePrecursorCell (OPC) in the vicinity of N:
      sense the InflammatorySignals released by Microglia
      activate DifferentiationSignaling to transform into mature Oligodendrocytes
      but the newly generated Oligodendrocytes fail to properly myelinate the Axons
        ; Due to the hostile inflammatory environment and impaired metabolic support
      hence SaltatoryConduction(Axon) is disrupted and ActionPotentialPropagation(Neuron) slows down
        ; Reduced efficiency and speed of information processing
        
    as a result:
      the Connectivity and ActivityPatterns of N become progressively disturbed
        ; Loss of synapses, altered neuronal excitability, disrupted network oscillations 
      leading to Neurodegeneration and Cognitive Decline characteristic of AD
        ; Accumulation of damage over years and decades 
  }
}